Director and PCA Dealings

Further to the Company's announcements on 26 November 2018 and 12 December 2018, MedaPhor announces that certain Directors, persons closely associated (“PCA”) with them and an employee have, following Admission today, acquired a total of 1,847,064 ordinary shares of 1 pence each in the Company ("Ordinary Shares") via the Placing: Click here to view full announcement. Enquiries: investors.medaphor.com/advisors   

December 13th, 2018|

Results of General Meeting and Total Voting Rights

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Accordingly, the Company has raised £5.08 million in the Placing and Open Offer and has issued and allotted 59,750,331 Placing and Open Offer Shares, conditional only on Admission becoming effective. Admission of the Placing and Open Offer Shares is expected at 8.00 a.m. on 13 December 2018. Following Admission, the Company's issued ordinary share capital will comprise 156,627,749 Ordinary Shares, of which none are held in treasury. The above [...]

December 12th, 2018|

Results of Open Offer

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, is pleased to announce that further to the announcement of the Placing and Open Offer on 26 November 2018, it has conditionally raised total gross proceeds of £78,778 via the Open Offer. The Open Offer closed for acceptances at 11.00 a.m. on 11 December 2018. The Company received valid acceptances from Qualifying Shareholders in respect of 926,801 Open Offer Shares, including applications for 63,354 Open Offer Shares under the Excess Application Facility. This represents 3.8 per cent. of the maximum Open Offer Shares available under the Open Offer. Admission of [...]

December 12th, 2018|